Pathway to Cures
Venture capital firm · Founded 2021 · New York, NY · New York ↗
Pathway to Cures (P2C) is the venture philanthropy fund of the National Bleeding Disorders Foundation, based in New York, using a mission-oriented investment model to fill the funding gap and invest in transformational therapies and technologies for people living with inheritable blood and bleeding disorders.
Tier reflects published scale and track-record signals. It is not a rating of the firm as a partner.
This profile is unclaimed. Built from public sources. If you're a partner or employee at Pathway to Cures, you can claim it.
Claim this profileHow claiming worksKey numbers
Assets under management
$3.5M
Latest fund
LAST CHECKED NOV 2026
Funds
LAST CHECKED NOV 2026
Check size
LAST CHECKED NOV 2026
Stages
No public record
Sectors
Inheritable Blood DisordersBleeding Disorders
FIGURES ARE AS PUBLISHED IN THE CATALOG RECORD 1 · PER-FIGURE AS-OF DATES ARE NOT YET IN THE CATALOG
Track record
Hits
Track record
Misses
Track record
Partners 2
Tim BrentManaging Director & Officer
Board seats
No public record
Teri WilleyFounding Managing Director Emeritus
Board seats
No public record
Reputation 2
No reputation score — basis not established for this firm.
- Business Wire - Pathway to Cures announces inaugural fund update
businesswire.com
Contact
Published sources only
Published contact
- Website
- www.pathwaytocures.org
- [email protected]
Published sources only
GlassVC lists only contact information the firm or its sources have published. We do not list personal emails, direct lines, or private addresses.
SOURCE: FIRM WEBSITE, AS PUBLISHED 2
What founders say
Founder-submitted · Verified identity and relationship
No founder reviews yet
Be the first founder to share your experience with Pathway to Cures. Reviews come from founders whose identity and relationship have been verified.
Write the first reviewMethodology
Tier basis — Grouped by disclosed AUM of $3.5M (AUM-band grouping — full tier basis pending in the catalog). Tier reflects published scale and track-record signals. It is not a rating of the firm as a partner.
Figures are shown as published; conflicting figures are never averaged. Review dimension scores appear only once three founders have reviewed this firm; profiles below that threshold do not appear in rated lists.
The catalog does not yet carry per-figure citations or as-of dates: every figure on this page traces to the catalog record listed below, and that limit is stated rather than papered over. Corrections with a source: Suggest a correction.
Source record 2
- [1]
DATABASE · GlassVC catalog — Catalog record for Pathway to Cures — provenance: GlassVC catalog census, November 2026
↩ cites: AUM · Check size · Founded · HQ · Stages · Sectors · Reputation
- [2]
FIRM SITE · Pathway to Cures — Firm website, as published by the firm
PROFILE BUILT FROM PUBLIC SOURCES · 2 CATALOG SOURCES · LAST CHECKED NOV 2026
